A5012698168- COVID-19 Clinical Research Studies
- Antibiotic Use and Resistance
- Mosquito-borne diseases and control
- COVID-19 and Mental Health
- Global Public Health Policies and Epidemiology
- COVID-19 and healthcare impacts
- Viral Infections and Vectors
- Kawasaki Disease and Coronary Complications
- SARS-CoV-2 and COVID-19 Research
Universidad del Valle de Guatemala
2023
Instituto de Salud del Estado de México
2021
There is an urgent need for effective treatments to prevent or attenuate lung and systemic inflammation, endotheliitis, thrombosis related COVID-19. This study aimed assess the effectiveness of a multidrug-therapy consisting Ivermectin, Azithromycin, Montelukast, Acetylsalicylic acid ("TNR4" therapy) hospitalization death among ambulatory COVID-19 cases in Tlaxcala, Mexico.
Background In Mexico, some of the most prevalent non-communicable diseases (NCDs) among adults are diabetes, hypertension, and chronic kidney disease (CKD). Mexico could be going through a syndemic dengue NCDs. This study aims to describe analyze association between prevalence NCDs hospitalization, presence hemorrhagic disorders, death in all officially confirmed cases during 2024. Methodology/Principal Findings cross-sectional is carried out secondary analysis reported The likelihood were...
Although COVID-19 (coronavirus disease 2019) in children is usually mild, they need hospitalization and intensive care exceptional cases. Adverse outcomes have been observed mainly among with comorbidities, justifying their vaccination. This study aimed to assess the risk of death Mexican adolescents comorbidities.A cross-sectional was performed on 366,542 confirmed cases under 18 years, reported by Ministry Health up July 9, 2022. Logistic regression models were performed.The mean age 10.98...